Member News

U.S. Food and Drug Administration approves CSL’s HEMGENIX® (etranacogene dezaparvovec-drlb), the first gene therapy for hemophilia B

Posted: 24 November Global biotechnology leader CSL announced that the U.S. Food and Drug Administration (FDA) approved HEMGENIX® (etranacogene dezaparvovec-drlb), the first and only one-time gene therapy for appropriate adults with hemophilia B. HEMGENIX is approved for the…

4DMedical Debuts “XV Scanner,” Most Advanced Lung Scanning Technology in Decades At RSNA

Posted: 18 November 4DMedical will unveil the “XV Scanner,” a breakthrough lung scanning device that integrates fluoroscopy with advanced analytics software at the 2022 annual meeting of the Radiological Society of North America (RSNA) in Chicago. The XV…

Phase 2 trial of ChulaCov19 BNA159 mRNA Vaccine to start in Australia

Posted: 18 November ChulaCov19 BNA159 is a COVID-19 mRNA vaccine developed by Chulalongkorn University and produced by BioNet • ChulaCov19 mRNA vaccine was found safe and immunogenic for primary immunization in clinical trials in Thailand. • The Australian…

ARCS Signature Program

Posted: 16 November Closes: 13 January 2023 The ARCS Signature Program is designed for senior executives and emerging leaders who are working in the med tech, biotech and pharmaceutical sectors. This includes those who are part of a…

Immutep Announces Compelling Clinical Results from Phase II Trial Utilizing its First-in-Class Soluble LAG-3 Protein, Eftilagimod Alpha, in 1st Line NSCLC

Posted: 11 November Immutep Limited, a clinical-stage biotechnology company developing novel LAG-3 immunotherapies for cancer and autoimmune disease, announced compelling new clinical data from the TACTI-002 all-comer PD-L1 Phase II trial evaluating Immutep’s lead product candidate, eftilagimod alpha…

Researchers make strides in the fight against COVID-19

Posted: 9 November New research from the Peter Doherty Institute of Infection and Immunity (Doherty Institute), The University of Melbourne and WEHI has unlocked key information in our understanding of molecular immune responses to COVID-19. Following COVID-19 infection,…

Virus discovery could help fight cancer

Posted: 9 November In a world first, La Trobe University researchers have discovered a virus that attacks a prominent disease-causing bacterium – a “ringleader” that recruits harmful bacteria to cause periodontitis, and potentially helps cancer grow and spread.…

Peter MacCallum Cancer Centre and Cartherics Announce Collaboration to Develop Autologous CAR-T Cell Therapy for Cutaneous T-Cell Lymphoma

Posted: 8 November The Peter MacCallum Cancer Centre (“Peter Mac”) and Cartherics Pty Ltd (“Cartherics”) announced that they have entered into a Collaborative Development Program Agreement (CDPA) to develop Cartherics’ proprietary autologous CAR-T cell therapy (CTH-001) for the…

Monash and Hudson Institute teams’ world-first for newborns

Posted: 4 November Melbourne scientists have discovered a way to treat seizures in newborns that will not only help protect their developing brain from further injury, but may also provide the first new, safe and effective treatment in decades.…

Landmark study finds home screening test can help prevent type 1 diabetes

Posted: 4 November Researchers have shown that a blood test for early diagnosis of type 1 diabetes can prevent serious illness and hospitalisation in children. The innovative test is a finger prick sample that is collected at home and…

CSL Enters Licensing Agreement with Arcturus Therapeutics for Next Generation mRNA Vaccine Technology

Posted: 4 November CSL Limited announced that its subsidiary, CSL Seqirus, has entered into a collaboration and license agreement with Arcturus Therapeutics Holdings Inc to access their late stage self-amplifying mRNA (sa-mRNA) vaccine platform technology. Arcturus Therapeutics is…

VivaZome executives to present at Annual Exosome Scientific Conference

Posted: 4 November VivaZome Therapeutics Pty Ltd (VivaZome) has announced that Ms Xenia Sango, Head of Regulatory and Clinical is speaking at Australia and New Zealand Society for Extracellular Vesicles (ANZSEV) in Gold Coast, Queensland 9 – 11…

Home

News & opinion

Member Directory

Events